Low expression of Granzyme B in colorectal cancer is associated with signs of early metastastic invasion

Histopathology

Volumn 59, Issue 2, 2011, Pages 207-215

  Salama, Paul ^a   Phillips, Michael ^b   Platell, Cameron ^a,c   Iacopetta, Barry ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c ST JOHN OF GOD HOSPITAL   (Australia)

Author keywords

CD8; Colorectal cancer; FoxP3; Granzyme B; Microsatellite instability; Prognosis; Vascular invasion

Indexed keywords

GRANZYME B; TRANSCRIPTION FACTOR FOXP3;

ARTICLE; CANCER INVASION; CANCER SURVIVAL; COLORECTAL CANCER; DIGITAL IMAGING; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; T LYMPHOCYTE; TISSUE MICROARRAY;

ADENOCARCINOMA; COLORECTAL NEOPLASMS; CYTOTOXINS; GRANZYMES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MICROSATELLITE INSTABILITY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; WESTERN AUSTRALIA;

ANIMALIA;

EID: 80052199122     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03915.x     Document Type: Article

References (38)

1. Gill S, Loprinzi CL, Sargent DJ et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J. Clin. Oncol. 2004; 22; 1797-1806.
2. Morris EJ, Maughan NJ, Forman D, Quirke P. Who to treat with adjuvant therapy in Dukes B/stage II colorectal cancer? The need for high quality pathology Gut 2007; 56; 1419-1425.
3. Petersen VC, Baxter KJ, Love SB, Shepherd NA. Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer. Gut 2002; 51; 65-69.
4. Compton CC, Fielding LP, Burgart LJ et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch. Pathol. Lab. Med. 2000; 124; 979-994.
5. Morris M, Platell C, de Boer B, McCaul K, Iacopetta B. Population-based study of prognostic factors in stage II colonic cancer. Br. J. Surg. 2006; 93; 866-871.
6. Stewart CJR, Morris M, de Boer B, Iacopetta B. Identification of serosal invasion and extramural venous invasion on review of Dukes' stage B colonic carcinomas and correlation with survival. Histopathology 2007; 51; 372-378.
7. Littleford SE, Baird A, Rotimi O, Verbeke CS, Scott N. Interobserver variation in the reporting of local peritoneal involvement and extramural venous invasion in colonic cancer. Histopathology 2009; 55; 407-413.
8. Shepherd NA, Baxter KJ, Love SB. The prognostic significance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology 1997; 112; 1096-1102.
9. House AK, Watt AG. Survival and the immune response in patients with carcinoma of the colorectum. Gut 1979; 20; 868-874.
10. Naito Y, Saito K, Shiiba K et al. CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res. 1998; 58; 3491-3494.
11. Galon J, Costes A, Sanchez-Cabo F et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313; 1960-1964.
12. Pages F, Berger A, Camus M et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N. Engl. J. Med. 2005; 353; 2654-2666.
13. Salama P, Phillips M, Grieu F et al. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J. Clin. Oncol. 2009; 27; 186-192.
14. Frey DM, Droeser RA, Viehl CT et al. High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients. Int. J. Cancer 2010; 126; 2635-2643.
15. Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat. Rev. Cancer 2005; 5; 263-274.
16. Koch M, Beckhove P, Op den Winkel J et al. Tumour infiltrating T lymphocytes in colorectal cancer: tumour-selective activation and cytotoxic activity in situ. Ann. Surg. 2006; 244; 986-992.
17. Mulder WM, Bloemena E, Stukart MJ, Kummer JA, Wagstaff J, Scheper RJ. T cell receptor-zeta and granzyme B expression in mononuclear cell infiltrates in normal colon mucosa and colon carcinoma. Gut 1997; 40; 113-119.
18. Peters PJ, Borst J, Oorschot V et al. Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J. Exp. Med. 1991; 173; 1099-1109.
19. Cullen SP, Martin SJ. Mechanisms of granule-dependent killing. Cell Death Differ. 2008; 15; 251-262.
20. Chowdhury D, Lieberman J. Death by a thousand cuts: granzyme pathways of programmed cell death. Annu. Rev. Immunol. 2008; 26; 389-420.
21. Chai SM, Zeps N, Shearwood AM et al. Screening for defective DNA mismatch repair in stage II and III colorectal cancer patients. Clin. Gastroenterol. Hepatol. 2004; 2; 1017-1125.
22. Bacus S, Flowers JL, Press MF, Bacus JW, McCarty KS Jr. The evaluation of estrogen receptor in primary breast carcinoma by computer-assisted image analysis. Am. J. Clin. Pathol. 1988; 90; 233-239.
23. Krajewska M, Smith LH, Rong J et al. Image analysis algorithms for immunohistochemical assessment of cell death events and fibrosis in tissue sections. J. Histochem. Cytochem. 2009; 57; 649-663.
24. Alvaro T, Lejeune M, Salvadó MT et al. Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clin. Cancer Res. 2005; 11; 1467-1473.
25. Kelley TW, Pohlman B, Elson P, Hsi ED. The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression. Am. J. Clin. Pathol. 2007; 128; 958-965.
26. Gao Q, Qiu SJ, Fan J et al. Intratumoural balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J. Clin. Oncol. 2007; 25; 2586-2593.
27. Sato E, Olson SH, Ahn J et al. Intraepithelial CD8+ tumour-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc. Natl Acad. Sci. USA 2005; 102; 18538-18543.
28. Le Gouvello S, Bastuji-Garin S, Aloulou N et al. High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas. Gut 2008; 57; 772-779.
29. Phillips SM, Banerjea A, Feakins R, Li SR, Bustin SA, Dorudi S. Tumour-infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic. Br. J. Surg. 2004; 91; 469-475.
30. Dolcetti R, Viel A, Doglioni C et al. High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability. Am. J. Pathol. 1999; 154; 1805-1813.
31. Mempel TR, Pittet MJ, Khazaie K et al. Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity 2006; 25; 129-141.
32. Liebig C, Ayala G, Wilks J et al. Perineural invasion is an independent predictor of outcome in colorectal cancer. J. Clin. Oncol. 2009; 27; 5131-5137.
33. Vermijlen D, Froelich CJ, Luo D, Suarez-Huerta N, Robaye B, Wisse E. Perforin and granzyme B induce apoptosis in FasL-resistant colon carcinoma cells. Cancer Immunol. Immunother. 2001; 50; 212-217.
34. Zlobec I, Lugli A. Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors. World J. Gastroenterol. 2009; 15; 5898-5906.
35. Pagès F, Galon J, Dieu-Nosjean MC, Tartour E, Sautès-Fridman C, Fridman WH. Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene 2010; 29; 1093-1102.
36. Wang Y, Jatkoe T, Zhang Y et al. Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. J. Clin. Oncol. 2004; 22; 1564-1571.
37. Barrier A, Boelle P, Roser F et al. Stage II colon cancer prognosis prediction by tumor gene expression profiling. J. Clin. Oncol. 2006; 24; 4685-4691.
38. Watanabe T, Kobunai T, Tanaka T, Ishihara S, Matsuda K, Nagawa H. Gene expression signature and the prediction of lymph node metastasis in colorectal cancer by DNA microarray. Dis. Colon Rectum 2009; 52; 1941-1948.